ProCE Banner Activity

CD38-Targeted Antibodies in Transplant-Eligible and Transplant-Ineligible Patients With Myeloma

Slideset

Downloadable slideset from a live webinar covering the use of CD38-targeted antibodies in the management of newly diagnosed multiple myeloma.

Released: July 24, 2024

Expiration: July 23, 2025

Share

Faculty

Thomas G. Martin

Thomas G. Martin, MD

Clinical Professor of Medicine
Associate Chief, Division of Hematology/Oncology
Co-Lead, Cancer Immunology and Immunotherapy Program
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi